Group One Trading’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
Other funds holding HOWL
LCM
DF
Group One Trading's HOWL Position: Q3 2026 in Review
Group One Trading sold out of Werewolf Therapeutics (HOWL) in Q3 2026, closing a stake of 1,871 shares — an estimated $673 sold.
Group One Trading first reported a position in HOWL in Q2 2022 and held it in 7 quarters. The position peaked at $5.26K in Q3 2025. 46 funds tracked by Wall St. Rank hold HOWL as of Q3 2026.
- Group One Trading reported no remaining Werewolf Therapeutics position as of Q3 2026 after selling out during the quarter.
- Group One Trading sold 1,871 Werewolf Therapeutics shares in Q3 2026, an estimated $673.
- Group One Trading first reported a position in Werewolf Therapeutics in Q2 2022 and held it in 7 quarters.
- Group One Trading's Werewolf Therapeutics position peaked at $5.26K in Q3 2025.
- 46 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.